Patent AnalyticsExaminers
Rankings

Company or institution

AbbVie Inc.

1,656 applicationsfiled 2006 to 2026

Allowance rate
59%
−17 pts vs the USPTO range 56% to 61%
Rejections before allowance
1.5
level with the USPTO
Months to first action
12.9 mo
−5.7 vs the USPTO
Needed an RCE
30%
+3 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds620 apps
A61K Medical preparations480 apps
C07K Peptides296 apps
A61M Devices for introducing media into the body47 apps
C07C 32 apps
G01N Investigating or analysing materials32 apps

Art units

1626200 apps
1624171 apps
1625147 apps
1644113 apps
162890 apps
164786 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19704173PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]…2026-06-10Allowed102.8 mo
19681875RISANKIZUMAB COMPOSITIONS2026-05-19Pending102.5 mo
19680812RISANKIZUMAB COMPOSITIONS2026-05-18Pending003.2 mo
15762758Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15818569Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15848257Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15848889Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15762048Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15872612Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15213560Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 1,656 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in